Supriya Lifescience Board of Directors
Get the latest insights into the leadership at Supriya Lifescience. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| Prachi Sathe | Company Secretary & Compliance Officer |
| Satish Waman Wagh | Chairman |
| Saloni Satish Wagh | Managing Director |
| Shivani Satish Wagh | Joint Managing Director |
| Smita Satish Wagh | Whole Time Director |
| Balasaheb Gulabrao Sawant | Whole Time Director |
| Neelam Yashpal Arora | Non Executive Independent Director |
| Ganapati Dadasaheb Yadav | Non Executive Independent Director |
| Sunil Subhash Bhagwat | Non Executive Independent Director |
| Kothandaraman Hari | Non Executive Independent Director |
| Manish Panchal | Non Executive Independent Director |
Supriya Lifescience FAQs
The board at Supriya Lifescience consists of experienced professionals, including Prachi Sathe, Satish Waman Wagh, and others, overseeing the company’s strategic and corporate governance.
Directors at Supriya Lifescience are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, Prachi Sathe is the current chairman at Supriya Lifescience.
Executive directors at Supriya Lifescience are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, Supriya Lifescience adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At Supriya Lifescience, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.
Supriya Lifescience Associated Pages
